EI
ACET icon

Ellevest Inc’s Adicet Bio ACET Stock Holding History

Ellevest Inc’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$72 – 1872
2022
Q4 		$72 Hold
1
– – ﹤0.01% 1773
2022
Q3 		$0 Sell
1
-2
-67% -$508 ﹤0.01% 1571
2022
Q2 		$1K Buy
3
+2
+200% +$439 ﹤0.01% 1201
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1379
2021
Q4 		$0 Hold
1
– – ﹤0.01% 1380
2021
Q3 		$0 Buy
+1
New +$124 ﹤0.01% 1370
2020
Q2 		– Hold
0
– – – 1101
2020
Q1 		– Hold
0
– – – 1064

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Ellevest Inc's ACET Position: Q1 2023 in Review

Ellevest Inc sold out of Adicet Bio (ACET) in Q1 2023, closing a stake of 1 share — an estimated $72 sold.

Ellevest Inc first reported a position in ACET in Q3 2021 and held it in 6 quarters. The position peaked at $1K in Q2 2022. 107 funds tracked by Wall St. Rank hold ACET as of Q1 2023.

  • Ellevest Inc reported no remaining Adicet Bio position as of Q1 2023 after selling out during the quarter.
  • Ellevest Inc sold 1 Adicet Bio share in Q1 2023, an estimated $72.
  • Ellevest Inc first reported a position in Adicet Bio in Q3 2021 and held it in 6 quarters.
  • Ellevest Inc's Adicet Bio position peaked at $1K in Q2 2022.
  • 107 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.